Ipamorelin 10mg
Growth hormone secretagogue peptide studied for GHS receptor signaling and growth hormone regulatory pathway research.
Compound Overview
Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue. It is studied in laboratory environments for its interaction with growth hormone secretagogue receptors (GHS-R) located in the pituitary and hypothalamus. Activation of these receptors is associated with signaling pathways involved in growth hormone release and endocrine regulation.
In experimental research models, Ipamorelin is frequently evaluated for receptor-binding activity, intracellular signaling cascades, and hormonal feedback mechanisms related to growth hormone modulation. Studies often investigate peptide-mediated signaling pathways within endocrine systems and the regulatory relationship between ghrelin receptors and pituitary hormone activity.
Receptor Activity
Studied for activation of growth hormone secretagogue receptors (GHS-R) involved in endocrine signaling pathways.
Endocrine Research Focus
Commonly evaluated in laboratory studies involving growth hormone regulation, pituitary signaling pathways, and peptide-mediated endocrine interactions.
Laboratory Classification
Classified as a growth hormone secretagogue peptide for experimental and analytical research applications.
Product Specifications
- Product Name: Ipamorelin
- Peptide Type: Growth hormone secretagogue
- Sequence Length: Pentapeptide
- Quantity: 10mg per vial
- Form: Lyophilized peptide powder
- Target Pathway: GHS receptor signaling
- Intended Use: Research use only






Reviews
There are no reviews yet.